← Open Payments lookup

LINDSAY SHEETS: Open Payments

NPI 1386296838 · RECTOR, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$673 in 39 payments from 12 companies in 2025. Trend: 2023 $1,448 · 2024 $1,987 · 2025 $673

Food & beverage: $673
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$273
ABBVIE INC.15$135
Otsuka America Pharmaceutical, Inc.4$60
Amgen Inc.3$42
PFIZER INC.2$33
GlaxoSmithKline, LLC.2$30
Novo Nordisk Inc1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Lundbeck LLC1$18
Xeris Pharmaceuticals, Inc.1$17

Products named: UBRELVY, BREZTRI, REXULTI, FARXIGA, OTEZLA, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA.

Industry payments across AR — which companies pay providers there.